2016-04-28 14:56:51 UTC

GERD and Refractory GERD: A Case Based Approach

Chicago, IL.

Duration

28:35

About

Review of treatments GERD:

Download the session audio:

MP3 File

Download the PowerPoint presentation:

PPT File

About the Instructors

Stuart J. Spechler, MD, AGAF

Stuart Jon Spechler, M.D. is Chief of the Division of Gastroenterology at the VA North Texas Healthcare System, Professor of Medicine, and holder of the Berta M. and Cecil O. Patterson Chair in Gastroenterology at The University of Texas Southwestern Medical Center at Dallas.  Before coming to Dallas in 1997, Dr. Spechler was Director of the Center for Swallowing Disorders at the Beth Israel Deaconess Medical Center and Harvard Medical School.  Dr. Spechler’s clinical and translational research has focused primarily on disorders of the esophagus, especially gastroesophageal reflux disease and its complications including Barrett’s esophagus and esophageal adenocarcinoma. He described the condition known as “short-segment Barrett’s esophagus” in 1994.  He has chaired three VA Cooperative Studies on gastroesophageal reflux disease.  Dr. Spechler has published more than 300 scientific reports, editorials, review articles, and book chapters on esophageal disorders.  He has served on the editorial boards of numerous journals including Gastroenterology, Gut, Alimentary Pharmacology and Therapeutics, and Diseases of the Esophagus.  He is the lead author of the American Gastroenterological Association’s latest technical review and medical position statement on the management of Barrett’s esophagus.

More on GERD

More Data on PPI Use and Kidney Disease

Nov. 8, 2017

A new meta-analysis on PPIs and kidney disease makes mainstream headlines. Here is what you, and your patients, need to know.

New PPI Study on Gastric Cancer Generates Media Attention

Nov. 2, 2017

AGA provides talking points to help your patients understand the science behind the PPI study.

Image Challenge: Chronic Abdominal Pain and Cutaneous Swelling

Sept. 27, 2017

What caused five to eight week episodes of intermittent abdominal pain, diarrhea, and associated nontender, non-itchy cutaneous erythema and swelling in patient?